20160421 PR VEN Q1 2016 – V4 clean
Category: 2016
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allow their intratumoral delivery and an improved tumor-growth inhibition
Jean Baptiste Marchand, et al. AACR Annual Meeting 2016, April 16-20, 2016, E.N. MorialConvention Center, New Orleans, Louisiana Download the poster here Poster Presentation
Transgene Presents Pre-Clinical Data at AACR on a New Generation Oncolytic Viral Immunotherapy Armed with an Anti-PD1 Monoclonal Antibody (poster)
20160419 AACR Poster PR Final
Transgene Hires Two Senior Pharmaceutical Industry Executives to Join Leadership Team
20160317 Appointments PR Final
Transgene Reports 2015 Financial Results and Provides Outlook for 2016 (webcast)
20160309 FY 2015 results version FINALE
Transgene Announces Participation at Upcoming Investor Events
20160302 March April 2016 IR events ENG
Transgene and ABL Announce the Acquisition by ABL Europe of Transgene’s Production Asset
20160203 PR ABL TG SYMPHONY
EIB lends EUR 20m to Transgene
20160128 PR transgene BEI final version
Transgene Announces Financial Calendar for 2016
20160108 financial calendar_EN ver 1
Transgene enters new phase in its strategic development
20160107 Strategic update ENG clean
